INVE vs NBIX · rev $13.1M vs P/E 45, rev $1.77B
Identiv Inc (INVE) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Identiv Inc (INVE) is a building products & equipment company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported INVE revenue for 2026-06-30 was $13.1M. Net income was -$8.1M. Revenue was up 76.6% from 2026-03-31 to 2026-06-30. INVE currently screens at market cap $96.3M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
INVE currently screens at market cap $96.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the INVE and NBIX stock pages for the full models.
Not investment advice.